Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
- 15 April 2016
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 44 (5), 1107-1115
- https://doi.org/10.1002/jmri.25279
Abstract
Purpose To predict pathological response of breast cancer to neoadjuvant chemotherapy (NAC) based on quantitative, multiregion analysis of dynamic contrast enhancement magnetic resonance imaging (DCE‐MRI). Materials and Methods In this Institutional Review Board‐approved study, 35 patients diagnosed with stage II/III breast cancer were retrospectively investigated using 3T DCE‐MR images acquired before and after the first cycle of NAC. First, principal component analysis (PCA) was used to reduce the dimensionality of the DCE‐MRI data with high temporal resolution. We then partitioned the whole tumor into multiple subregions using k‐means clustering based on the PCA‐defined eigenmaps. Within each tumor subregion, we extracted four quantitative Haralick texture features based on the gray‐level co‐occurrence matrix (GLCM). The change in texture features in each tumor subregion between pre‐ and during‐NAC was used to predict pathological complete response after NAC. Results Three tumor subregions were identified through clustering, each with distinct enhancement characteristics. In univariate analysis, all imaging predictors except one extracted from the tumor subregion associated with fast washout were statistically significant (P < 0.05) after correcting for multiple testing, with area under the receiver operating characteristic (ROC) curve (AUC) or AUCs between 0.75 and 0.80. In multivariate analysis, the proposed imaging predictors achieved an AUC of 0.79 (P = 0.002) in leave‐one‐out cross‐validation. This improved upon conventional imaging predictors such as tumor volume (AUC = 0.53) and texture features based on whole‐tumor analysis (AUC = 0.65). Conclusion The heterogeneity of the tumor subregion associated with fast washout on DCE‐MRI predicted pathological response to NAC in breast cancer. J. Magn. Reson. Imaging 2016;44:1107–1115.Funding Information
- National Institutes of Health (NIH) (R01 CA193730)
This publication has 37 references indexed in Scilit:
- DCE‐MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findingsMagnetic Resonance in Medicine, 2013
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIALRadiology, 2012
- Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancerJournal of Magnetic Resonance Imaging, 2010
- Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRIJournal of Magnetic Resonance Imaging, 2009
- Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast CancerClinical Cancer Research, 2008
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and PrognosisThe Oncologist, 2008
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial resultsMagnetic Resonance Imaging, 2007
- Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2006
- A dendrite method for cluster analysisCommunications in Statistics - Theory and Methods, 1974